<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p><span ><strong>Pneumonia</strong></span></p><p><span >Pneumonia is an infection of the lung tissue caused by various bacteria, viruses or fungi. Identification of the causative organism and drug sensitivity testing is the key to correct treatment. However, because of the serious nature of the infection, antibiotic treatment should be started immediately based on knowledge of the most probable causative organism and the antibiotics used for its treatment. Local knowledge of drug resistance patterns are also taken into account. Treatment may be maintained or changed based on culture results and assessment of the patient's response to initial treatment. In the event that the cultures of blood or sputum prove negative, empiric treatment is continued with clinical response as a guide. </span></p><p><span >The severity of the illness is a key factor in the decision for admission, and the choice of first or second-line treatment.</span></p><p> </p>
    
    <table>
        <tbody>
        <tr>
        <td>
        <p><strong>Box 8-1: Severity score for community acquired pneumonia (CURB-65)</strong></p>
        </td>
        </tr>
        <tr>
        <td>
        <p>Severity score may be based on the following, assigning one point to each of the following factors (maximum 5 points);</p>
        <p>&bull; Confusion, restlessness, or excessive drowsiness</p>
        <p>&bull; Blood Urea Nitrogen ( &gt; 7 mmol/L)</p>
        <p>&bull; Respiratory rate ( 2" 30 per minute in adults, and 2" 50 in children)</p>
        <p>&bull; Low BP (Systolic BP &lt; 90 and/or diastolic BP &lt; 60 mmHg)</p>
        <p>&bull; Patients at the extremes of age, (&lt; 5yr or 2" 65yr)</p>
        </td>
        </tr>
        <tr>
        <td>
        <p>0-1; consider home treatment</p>
        <p>2-3; consider short inpatient hospitalisation</p>
        <p>&gt; 3; admit and consider intensive care</p>
        </td>
        </tr>
        </tbody>
        </table>
        <p> </p>
        <table>
        <tbody>
        <tr>
        <td>
        <p><strong>Box 8-1: Severity score for community acquired pneumonia (CURB-65)</strong></p>
        </td>
        </tr>
        <tr>
        <td>
        <p>In the presence any of the following additional factors, all cases of pneumonia would warrant hospitalisation.</p>
        </td>
        </tr>
        <tr>
        <td>
        <p>Additional factors</p>
        <p>&bull; Coexisting diseases such as chronic lung disease, heart failure or renal disease</p>
        <p>&bull; Extensive disease, multiple lobes involved</p>
        <p>&bull; Low oxygen saturation Sp02 , &lt; 92% on room air</p>
        <p>&bull; Severe tachycardia</p>
        </td>
        </tr>
        </tbody>
        </table>    
    
<h3>CAUSES</h3><h3><strong>Community acquired pneumonia</strong></h3><ul><li><i>Streptococcus pneumonia</i></li><li><i>Streptococcus pyogenes</i></li><li><i>Haemophilus influenza</i></li><li><i>Klebsiella pneumoniae</i></li><li>Mycoplasma pneumonia and <i>Legionella pneumophila </i>(tend to occur in epidemics)</li><li> <i>Staphylococcus aureus</i>(in children after viral illness like measles, in diabetics or in the elderly during 'flu' epidemics)</li></ul><h3>Aspiration pneumonia</h3><ul><li> Anaerobic and/or gram negative organisms (associated with aspiration e.g. stroke, seizures, unconsciousness)</li></ul><h3>Hospital acquired pneumonia</h3><ul><li>Gram-negative bacteria e.g. <i>Pseudomonas aeruginosa</i></li><li>MRSA (Methicillin resistant)</li><li>VRSA (Vancomycin resistant)</li><li><i>Staphylococcus aureus</i></li></ul><h3>Others</h3><ul><li><i>Pneumocystis jiroveci </i>pneumonia and other fungi (in immunocompromised states e.g. haematological malignancies, HIV/ AIDS</li><li>Viruses</li></ul><h3>SYMPTOMS</h3><p> • Fever - short history</p><p> • Productive cough</p><p> • Sputum - rusty or blood stained, yellowish, greenish</p><p> • Pleuritic chest pain - worse on deep breathing or coughing</p><p> • Breathlessness</p><p> • Sweating</p><p> • Muscle aches</p><p> • Elderly and immunocompromised patients may have minimum or no symptoms</p><h3>SIGNS</h3><ul><li>Rapid breathing</li><li>Grunting (in children)</li><li>Use of accessory muscles of respiration and flaring of the nasal margins</li><li>Lower chest wall indrawing (in children)</li><li>Restricted movement of the affected side of the chest (due to pain)</li><li>Fever</li><li>Rapid pulse rate</li><li>Blood pressure may be normal or low</li><li>Signs of consolidation or pleural effusion on chest examination</li><li>Restlessness or confusion, drowsiness</li><li>Low blood oxygen saturation by pulse oximetry &lt; 92%</li></ul><h3>COMPLICATIONS</h3><ul><li>Pleural effusion</li><li>Lung abscess</li><li>Empyema</li><li>Pericardial effusion/pericarditis</li><li>Pneumothorax particularly <i>Staph. aureus </i>infection, <i>Pneumocystis jiroveci </i>pneumonia</li><li>Meningitis</li><li>Septicaemia with multi organ failure</li><li>Adult respiratory distress syndrome (ARDS)</li></ul><h3>INVESTIGATIONS</h3><ul><li>FBC</li><li>C-reactive protein (CRP)</li><li>Chest X-ray</li><li>Sputum gram stain and culture and sensitivity</li><li>Ziehl-Neelsen stain for acid-fast bacilli (to exclude TB)</li><li>Blood culture and sensitivity</li><li>Blood urea and electrolytes</li></ul><h3>TREATMENT</h3><h3><strong>Treatment objectives</strong></h3><ul><li>To identify patients at greater risk who require in-hospital management</li><li>To alleviate symptoms</li><li>To treat and eradicate the infection</li><li>To prevent and/or manage complications</li></ul><h3>Non-pharmacological treatment</h3><ul><li>Nurse in comfortable position, usually with head raised</li><li>Sponging to control fever, especially in children &lt; 5 years (who are at risk of febrile convulsions)</li><li>Adequate oral hydration (if it can be tolerated)</li><li>Chest physiotherapy</li></ul><p style="margin-left:0in;"> </p><h3>Pharmacological treatment</h3><p><span ><strong>A. Ambulatory patient: low severity score &lt; 2 (see above)</strong></span></p><p><span ><strong>1<sup>st</sup> Line Treatment Evidence Rating: [A]</strong></span></p><ul><li>Amoxicillin (Amoxycillin), oral,</li></ul><p><strong><u>Adults</u></strong></p><p>1 g 8 hourly for 7 days (high dose)</p><p><strong><u>Children</u></strong></p><p>5-12 years; 500 mg 8 hourly for 7 days</p><p>1-5 years;   250 mg 8 hourly for 7 days</p><p>6 months-1 year; 125 mg 8 hourly for 7 days</p><p><strong>And</strong></p><ul><li>Azithromycin, oral,</li></ul><p><strong><u>Adult</u></strong></p><p>500 mg daily for 6 days</p><p><strong><u>Children</u></strong></p><p>10 mg/kg daily for 6 days</p><p><strong>Or</strong></p><ul><li>Erythromycin, oral, (if patient is allergic to penicillin)</li></ul><p><strong><u>Adult</u></strong></p><p>500 mg 6 hourly for 7 days</p><p><strong><u>Children</u></strong></p><p>8-18 years; 250-500 mg 6 hourly for 7 days</p><p>2-8 years; 250 mg 6 hourly for 7 days</p><p>6 months-2 years; 25 mg 6 hourly for 7 days</p><p><span ><strong>2<sup>nd</sup> Line Treatment Evidence Rating: [A]</strong></span></p><ul><li>Cefuroxime, oral,</li></ul><p><strong><u>Adults</u></strong></p><p>500 mg 12 hourly for 7 days</p><p><strong><u>Children</u></strong></p><p>3 months-12 years;  30 mg/kg/day in two divided doses for 7days</p><p>12 years;  250-500 mg 12 hourly for 7 days</p><p><strong>Or</strong></p><ul><li>Doxycycline, oral,</li></ul><p><strong><u>Adults</u></strong></p><p>100 mg 12 hourly for 7-14 days depending on severity</p><p><span ><strong>B. Hospitalized patient: Severity score, Or with additional factors as mentioned above</strong></span></p><ul><li>Oxygen, by face mask or nasal prongs,</li></ul><p><u>Adults</u> and <u>Children</u></p><p>Maintain oxygen saturation &gt; 92%</p><h3 style="margin-left:98.4pt;">And</h3><ul><li>IV fluids as normal saline and dextrose saline to replace estimated insensible loss</li></ul><h3 style="margin-left:98.4pt;">And</h3><ul><li>Paracetamol, oral,</li></ul><p><strong><u>Adults</u></strong></p><p>500 mg-1g 6-8 hourly</p><p><strong><u>Children</u></strong></p><p>6-12 years;  250-500 mg 6-8 hourly</p><p>1-5 years;   120-250 mg 6-8 hourly</p><p>3 months-1 year;   60-120 mg 6-8 hourly</p><h3 style="margin-left:98.4pt;">Or</h3><ul><li>Paracetamol suppository<u> </u></li><li><strong><u>Adults</u> and <u>children</u> doses as above</strong></li></ul><h3 style="margin-left:98.4pt;">And</h3><ul><li>Amoxicillin + Clavulanic Acid, IV, (change to oral route when patient improves)</li></ul><p><strong><u>Adults</u></strong></p><p>1.2 g  8 hourly for 7-10 days</p><p><strong><u>Children</u></strong></p><p>3 months-18 years; 30 mg/kg 8 hourly, max. 1.2 g 8 hourly for 7-10 days</p><p>&lt; 3 months; 30 mg/kg 12 hourly for 7-10 days</p><h3 style="margin-left:98.4pt;">And</h3><ul><li>Azithromycin, oral,</li></ul><p><strong><u>Adult</u></strong></p><p>500 mg daily for 3-7 days</p><p><strong><u>Children</u></strong></p><p>10 mg/kg once daily for 3-7 days</p><h3 style="margin-left:98.4pt;">Or</h3><ul><li>Azithromycin, IV,</li></ul><p><strong><u>Adult</u></strong></p><p>500 mg daily for 3 days</p><p>Revert to oral azithromycin, when clinically stable to complete 7 days of treatment. (See section on treatment for ambulatory patients above).</p><p><strong><u>Children</u></strong></p><p>IV route not recommended in children for pneumonia treatment</p><p><span ><strong>2<sup>nd</sup> line treatment Evidence Rating: [A]</strong></span></p><ul><li>Ceftriaxone, IV,</li></ul><p><strong><u>Adult</u></strong></p><p>2 g daily for 7-10 days</p><p><strong><u>Children</u></strong></p><p>All ages 25 mg/kg 12 hourly (max. 75 mg/kg daily)</p><h3 style="margin-left:98.4pt;">And</h3><ul><li>Azithromycin, IV (as above)</li></ul><ol><li><span >Treatment for aspiration pneumonia</span></li><li><span ><strong>1<sup>st</sup> Line treatment Evidence Rating: [B]</strong></span></li></ol><ul><li>Ceftriaxone, IV,</li></ul><p><strong><u>Adult</u></strong></p><ol><li>g daily for 7-10 days</li></ol><p><strong><u>Children</u></strong></p><p>      All ages 50-75 mg/kg/day in divided 12 hourly doses</p><h3 style="margin-left:98.4pt;">Or</h3><ul><li>Amoxicillin + Clavulanic Acid, IV, (change to oral route when patient improves)</li></ul><p><strong><u>Adults</u></strong></p><p>1.2 g 8 hourly for 7-10 days</p><p><strong><u>Children</u></strong></p><ol><li>months-18 years;  30 mg/kg 8 hourly, max 1.2 g 8 hourly for 7-10 days</li></ol><p>    &lt; 3 months; 30 mg/kg 12 hourly for 7-10 days</p><h3 style="margin-left:98.4pt;">Or</h3><ul><li>Ciprofloxacin, IV, (to be administered over 60 minutes)</li></ul><p><strong><u>Adults</u></strong></p><p>400 mg 8-12 hourly for 7 days</p><p><strong><u>Children</u></strong></p><p>10 mg/kg (max. 400 mg) 12 hourly for 7 days</p><h3 style="margin-left:98.4pt;">And</h3><ul><li>Metronidazole, IV,</li></ul><p><strong><u>Adults</u></strong></p><p>500 mg 8 hourly for 7 days</p><p><strong><u>Children</u></strong></p><p>7.5 mg/kg 8 hourly for 7 days</p><h3 style="margin-left:98.4pt;">              Or</h3><ul><li style="margin-left:98.4pt;">Clindamycin, IV,</li></ul><p><strong><u>Adults</u></strong></p><p>300-600 mg  6 hourly for 7 days</p><p><strong><u>Children</u></strong></p><p>3-6 mg/kg 6 hourly for 7 days</p><h3>REFERRAL CRITERIA</h3><h3><span >Refer to the paediatrician or physician specialist if no improvement occurs (i.e. fever remains high, patient is still breathless, or repeat X-rays show complications or no resolution).</span></h3><p > </p>
</body>
</html>
